University of Nebraska Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2012

  1. Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: A phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

    British Journal of Cancer, Vol. 107, Núm. 5, pp. 808-813